NYSE:HCP

HCP Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$36.97
-0.17 (-0.46 %)
(As of 07/30/2021 12:00 AM ET)
Add
Compare
Today's Range
$36.86
$37.69
50-Day Range
$28.42
$35.78
52-Week Range
$26.58
$37.93
Volume4.66 million shs
Average Volume3.01 million shs
Market Capitalization$18.16 billion
P/E Ratio20.31
Dividend Yield4.14%
Beta0.22

Receive HCP News and Ratings via Email

Sign-up to receive the latest news and ratings for HCP and its competitors with MarketBeat's FREE daily newsletter.


HCP logo

About HCP

HCP, Inc. is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.66 out of 5 stars

Finance Sector

1056th out of 2,041 stocks

Real Estate Investment Trusts Industry

213th out of 283 stocks

Analyst Opinion: 0.0Community Rank: 3.7Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











HCP (NYSE:HCP) Frequently Asked Questions

What stocks does MarketBeat like better than HCP?

Wall Street analysts have given HCP a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but HCP wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were HCP's earnings last quarter?

HCP, Inc. (NYSE:HCP) issued its earnings results on Wednesday, October, 30th. The real estate investment trust reported ($0.09) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.43 by $0.52. The real estate investment trust earned $538 million during the quarter, compared to the consensus estimate of $503.65 million. HCP had a net margin of 43.66% and a trailing twelve-month return on equity of 12.78%. The business's quarterly revenue was up 18.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.44 earnings per share.
View HCP's earnings history
.

Is HCP a good dividend stock?

HCP pays an annual dividend of $1.48 per share and currently has a dividend yield of 4.14%. HCP has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio of HCP is 81.32%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, HCP will have a dividend payout ratio of 80.87% in the coming year. This indicates that HCP may not be able to sustain their current dividend.
View HCP's dividend history.

Who are HCP's key executives?

HCP's management team includes the following people:
  • Mr. Thomas M. Herzog, Pres, CEO & Director (Age 56)
  • Mr. Peter A. Scott, Exec. VP & CFO (Age 39)
  • Mr. Thomas M. Klaritch, Exec. VP, COO & Chief Devel. Officer (Age 61)
  • Mr. Scott M. Brinker, Exec. VP & Chief Investment Officer (Age 42)
  • Mr. Troy E. McHenry, Exec. VP, Gen. Counsel & Corp. Sec. (Age 46)

Who are some of HCP's key competitors?

What other stocks do shareholders of HCP own?

Based on aggregate information from My MarketBeat watchlists, some companies that other HCP investors own include AT&T (T), Welltower (WELL), Omega Healthcare Investors (OHI), Intel (INTC), Realty Income (O), AbbVie (ABBV), Cisco Systems (CSCO), Verizon Communications (VZ), Johnson & Johnson (JNJ) and The Walt Disney (DIS).

What is HCP's stock symbol?

HCP trades on the New York Stock Exchange (NYSE) under the ticker symbol "HCP."

What is HCP's stock price today?

One share of HCP stock can currently be purchased for approximately $36.97.

How much money does HCP make?

HCP has a market capitalization of $18.16 billion and generates $1.85 billion in revenue each year. The real estate investment trust earns $1.06 billion in net income (profit) each year or $1.82 on an earnings per share basis.

How many employees does HCP have?

HCP employs 201 workers across the globe.

What is HCP's official website?

The official website for HCP is www.hcpi.com.

Where are HCP's headquarters?

HCP is headquartered at 1920 MAIN STREET SUITE 1200, IRVINE CA, 92614.

How can I contact HCP?

HCP's mailing address is 1920 MAIN STREET SUITE 1200, IRVINE CA, 92614. The real estate investment trust can be reached via phone at 949-407-0700 or via email at [email protected]


This page was last updated on 8/1/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.